Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Noske

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Orthopaedics|December 6, 2002
Suprascapular nerve entrapment. A meta-analysisHarald Zehetgruber, H Noske, T Lang, et al.
Pediatric Blood & Cancer|October 7, 2004
Soluble p185(HER-2) in patients with malignant bone tumoursG Holzer, T Pfandlsteiner, M Koschat, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 24, 2002
Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donationC Wurnig, K Schatz, H Noske, et al.
Journal of Clinical Pharmacy and Therapeutics|October 16, 2004
Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosisE Cauza, M Etemad, F Winkler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Orthopaedics|December 6, 2002
Suprascapular nerve entrapment. A meta-analysisHarald Zehetgruber, H Noske, T Lang, et al.
Pediatric Blood & Cancer|October 7, 2004
Soluble p185(HER-2) in patients with malignant bone tumoursG Holzer, T Pfandlsteiner, M Koschat, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 24, 2002
Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donationC Wurnig, K Schatz, H Noske, et al.
Journal of Clinical Pharmacy and Therapeutics|October 16, 2004
Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosisE Cauza, M Etemad, F Winkler, et al.
Pageof 1